Ferric Carboxymaltose [Ferinject]
Elderly (People Aged 65 or More)
Fundación para la Investigación del Hospital Clínico de ValenciaPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Elderly (People Aged 65 or More) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin Junpeng Wang | Phase 2 | CCC |
Raltitrexed Junpeng Wang | Phase 2 | CCC |
Idarubicine Junpeng Wang | Phase 2 | CCC |
Inno-206 Junpeng Wang | Phase 2 | CCC |
Same molecule, other indications
Ferric Carboxymaltose [Ferinject] is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →